FDMT vs MTB · rev $37.0K vs P/E 12, $30.99B cap
4D Molecular Therapeutics Inc (FDMT) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
MTB does not have a complete income-statement cache yet.
FDMT currently screens at market cap $518.1M. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the FDMT and MTB stock pages for the full models.
Not investment advice.